Literature DB >> 8237985

Comparison of recalled and validated oral contraceptive histories.

P Nischan1, K Ebeling, D B Thomas, U Hirsch.   

Abstract

From a case-control study of the relation between oral contraceptives and breast cancer carried out in East Germany during 1982-1986, the authors obtained information on oral contraceptive use through interviews of study subjects and from the records of prescribing gynecologists. The degree of agreement regarding information from these two sources was assessed for 234 breast cancer cases and 524 controls who had ever used oral contraceptives. Agreement between information obtained from medical records and that from interviews on total duration of use, number of episodes of use, and time since first and last use was reasonably good, and levels of agreement did not differ appreciably between cases and controls. Lower levels of agreement were observed for individual brand names and the duration of use of specific brands. Attempts should be made to obtain information on specific brands from medical records when investigating the effects of individual preparations.

Entities:  

Keywords:  Bias; Breast Cancer; Cancer; Case Control Studies; Contraception; Contraceptive Methods--side effects; Diseases; Eastern Europe; Epidemiologic Methods; Error Sources; Europe; Family Planning; German Democratic Republic; Information; Information Processing; Measurement; Neoplasms; Oral Contraceptives, Combined--side effects; Oral Contraceptives, Phasic; Oral Contraceptives--side effects; Records; Research Methodology; Studies

Mesh:

Substances:

Year:  1993        PMID: 8237985     DOI: 10.1093/oxfordjournals.aje.a116907

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  19 in total

1.  Oral contraceptive use among women in the military and the general U.S. population.

Authors:  Lindsey Enewold; Louise A Brinton; Katherine A McGlynn; Shelia H Zahm; John F Potter; Kangmin Zhu
Journal:  J Womens Health (Larchmt)       Date:  2010-05       Impact factor: 2.681

2.  Oral contraceptives and breast cancer risk overall and by molecular subtype among young women.

Authors:  Elisabeth F Beaber; Kathleen E Malone; Mei-Tzu Chen Tang; William E Barlow; Peggy L Porter; Janet R Daling; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-14       Impact factor: 4.254

3.  A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women.

Authors:  Leslie Spangler; Laura E Ichikawa; Rebecca A Hubbard; Belinda Operskalski; Andrea Z LaCroix; Susan M Ott; Delia Scholes
Journal:  Ann Epidemiol       Date:  2014-10-16       Impact factor: 3.797

4.  Comparison of prospective daily diaries and retrospective recall to measure oral contraceptive adherence.

Authors:  Larissa R Brunner Huber; Elizabeth C Broel; Ashley N Mitchelides; Jacek Dmochowski; Michael Dulin; Delia Scholes
Journal:  Contraception       Date:  2013-03-15       Impact factor: 3.375

5.  Recent oral contraceptive use by formulation and breast cancer risk among women 20 to 49 years of age.

Authors:  Elisabeth F Beaber; Diana S M Buist; William E Barlow; Kathleen E Malone; Susan D Reed; Christopher I Li
Journal:  Cancer Res       Date:  2014-08-01       Impact factor: 12.701

6.  Depot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infection.

Authors:  Tiffany G Harris; Leslie Miller; Shalini L Kulasingam; Qinghua Feng; Nancy B Kiviat; Stephen M Schwartz; Laura A Koutsky
Journal:  Am J Obstet Gynecol       Date:  2009-05       Impact factor: 8.661

7.  Oral contraceptive use and the prognosis of breast cancer.

Authors:  I Schönborn; P Nischan; K Ebeling
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions.

Authors:  Marleen M Welsh; Margaret R Karagas; Katie M Applebaum; Steven K Spencer; Ann E Perry; Heather H Nelson
Journal:  Carcinogenesis       Date:  2008-07-18       Impact factor: 4.944

9.  Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.

Authors:  I Schönborn; W Zschiesche; C Minguillon; E Spitzer; M Möhner; K Ebeling; R Grosse
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  Oral contraceptives: a risk factor for squamous cell carcinoma?

Authors:  Katie M Applebaum; Heather H Nelson; Michael S Zens; Therese A Stukel; Steven K Spencer; Margaret R Karagas
Journal:  J Invest Dermatol       Date:  2009-06-25       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.